ANI Pharmaceuticals reported $15.17M in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
AbbVie USD 5.72B 69M Jun/2025
ANI Pharmaceuticals USD 15.17M 10.3M Jun/2025
Aurora Cannabis CAD -17609000 54.46M Jun/2025
Canopy Growth CAD -31497000 7.68M Jun/2025
Eli Lilly USD 7.02B 3.32B Jun/2025
Hikma Pharmaceutical USD 317M 85M Dec/2024
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Novartis USD 4.82B 39M Jun/2025
Perrigo USD 55.6M 91M Jun/2025
Sun Pharmaceuticals INR 32.48B 1.95B Jun/2025
Teva Pharmaceutical Industries USD 406M 540M Jun/2025